Depression that doesn’t respond to conventional treatments is a serious problem for all who are affected, and poses unique risks...
Read More
On September 6, 2022, the U.S. Food and Drug Administration cleared the way for marketing of a rapid-acting brain-stimulation approach...
Read More
Researchers have published results of experiments in rodents suggesting that lithium, a widely prescribed mood stabilizer, may have value as...
Read More
In its first randomized, placebo-controlled test, an enhanced form of non-invasive brain stimulation called SNT (Stanford Neuromodulation Therapy, formerly called...
Read More
A research team led in part by two BBRF grantees has reported initial success in using a novel, highly personalized,...
Read More